RYAN · Ryan Specialty Holdings, Inc.
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted compensation and benefits expense non-GAAP | 956.78M | Six Months Ended June 30, 2026 | — |
|
|
|||
| Adjusted compensation and benefits expense ratio non-GAAP | 55.9% | Six Months Ended June 30, 2026 | — |
|
|
|||
| Adjusted diluted earnings per share non-GAAP | $1.22 | Six Months Ended June 30, 2026 | — |
|
|
|||
| Adjusted EBITDAC non-GAAP | $558.94M | Six Months Ended June 30, 2026 | — |
|
|
|||
| Adjusted EBITDAC margin non-GAAP | 32.7% | Six Months Ended June 30, 2026 | — |
|
|
|||
| Adjusted general and administrative expense non-GAAP | 196.16M | Six Months Ended June 30, 2026 | — |
|
|
|||
| Adjusted net income non-GAAP | $329.46M | Six Months Ended June 30, 2026 | — |
|
|
|||
| Adjusted net income margin non-GAAP | 19.2% | Six Months Ended June 30, 2026 | — |
|
|
|||
| Capital returned to shareholders | $284.5M | Q2 2026 | — |
|
|
|||
| Class A common stock repurchased | 8.1M | Q2 2026 | — |
| Dividends and distributions | $24.5M | Q2 2026 | — |
|
|
|||
| Organic revenue growth rate non-GAAP | 8.9% | Six Months Ended June 30, 2026 | — |
|
|
|||
| Share repurchase program authorization | $300M | As of June 30, 2026 | — |
| Share repurchases | $260M | Q2 2026 | — |
|
|
|||
| Adjusted general and administrative expense ratio non-GAAP | 12.7% | Three Months Ended March 31, 2026 | — |
|
|
|||
| Cash returned to shareholders through repurchases | $40M | Three Months Ended March 31, 2026 | — |
| Credit Adjusted EBITDAC non-GAAP | $1.05B | Twelve Months Ended March 31 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Adjusted EBITDAC 998.27M
+48.39M Credit adjustments
= Credit Adjusted EBITDAC 1.05B
|
|||
| Remaining Share Repurchase Authorization | $260M | As of March 31, 2026 | — |
| Shares Repurchased | 1M | Q1 FY2026 | — |
| Adjusted diluted earnings per share diluted share count non-GAAP | 279.03M | Year Ended December 31, 2025 | — |
| Organic revenue growth non-GAAP | 6.6% | Q4 2025 | — |
| Organic revenue growth (Non-GAAP) non-GAAP | 240.34M | Year Ended December 31, 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Insurance - Specialty — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
RYAN
this stock
Ryan Specialty Holdings, Inc.
|
$11.19B | -15.0% | +21.3% | — | 5.2% |
|
FNF
Fidelity National Financial, Inc.
|
$12.69B | -12.9% | +5.6% | — | 3.1% |
|
FAF
First American Financial Corp
|
$7.61B | +21.2% | +21.6% | 10.3 | 5.5% |
|
AXS
Axis Capital Holdings Ltd
|
$7.37B | -7.1% | +10.2% | 7.5 | 2.8% |
|
ACT
Enact Holdings, Inc.
|
$6.75B | +23.8% | +2.8% | 10.3 | 1.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| RYAN | +1.4% | -0.7% | +15.9% | -0.7% | -15.0% |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | +0.9% | -3.7% | +2.5% | -3.7% | -27.9% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.